Adage Capital Partners
ANVS icon

Adage Capital Partners’s Annovis Bio ANVS Stock Holding History

Adage Capital Partners’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,000
Closed -$576K – 869
2024
Q2 		$576K Sell
100,000
-150,000
-60% -$1.22M ﹤0.01% 813
2024
Q1 		$2.98M Sell
250,000
-35,347
-12% -$386K 0.01% 751
2023
Q4 		$5.34M Sell
285,347
-14,653
-5% -$130K 0.01% 675
2023
Q3 		$2.85M Buy
+300,000
New +$3.71M 0.01% 721

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Adage Capital Partners's ANVS Position: Q3 2024 in Review

Adage Capital Partners sold out of Annovis Bio (ANVS) in Q3 2024, closing a stake of 100,000 shares — an estimated $576K sold.

Adage Capital Partners first reported a position in ANVS in Q3 2023 and held it in 4 quarters. The position peaked at $5.34M in Q4 2023. 35 funds tracked by Wall St. Rank hold ANVS as of Q3 2024.

  • Adage Capital Partners reported no remaining Annovis Bio position as of Q3 2024 after selling out during the quarter.
  • Adage Capital Partners sold 100,000 Annovis Bio shares in Q3 2024, an estimated $576K.
  • Adage Capital Partners first reported a position in Annovis Bio in Q3 2023 and held it in 4 quarters.
  • Adage Capital Partners's Annovis Bio position peaked at $5.34M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2024.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.